Recurrence Score Helps in Selecting T1-2N1 Breast Cancer Patients for Individualized Postmastectomy Radiotherapy - Joint Analysis of 2793 Patients from Two Institutions

被引：0
|
作者：
Wang, S. [1 ,2 ,3 ]
Wen, G. [4 ,5 ]
Tang, Y. [1 ,2 ,3 ]
Yang, Y. [3 ,6 ,7 ]
Peng, R. [1 ,2 ,3 ]
Jing, H. [1 ,2 ,3 ]
Wang, J. [1 ,2 ,3 ]
Zhang, J. [1 ,2 ,3 ]
Zhao, X. [1 ,2 ,3 ]
Sun, G. [1 ,2 ,3 ]
Jin, J. [1 ,2 ,3 ]
Liu, Y. [1 ,2 ,3 ]
Song, Y. [1 ,2 ,3 ]
Fang, H. [1 ,2 ,3 ]
Ren, H. [1 ,2 ,3 ]
Tang, Y. [1 ,2 ,3 ]
Qi, S. [1 ,2 ,3 ]
Li, N. [1 ,2 ,3 ]
Chen, B. [1 ,2 ,3 ]
Lu, N. [1 ,2 ,3 ]
Yu, Z. [1 ,2 ,3 ]
Zhang, Y. [8 ]
Li, Y. [1 ,2 ,3 ]
机构：
[1] CAMS, Canc Hosp, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol,Natl Canc Ctr, Beijing, Peoples R China
[2] CAMS, Canc Hosp, Natl Clin Res Ctr Canc, Dept Radiat Oncol,Natl Canc Ctr, Beijing, Peoples R China
[3] PUMC, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Radiat Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 3, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China
[6] CAMS, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China
[7] CAMS, Ctr Canc Precis Med, Beijing, Peoples R China
[8] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.700
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2083
引用
收藏
页码：E37 / E37
页数：1
相关论文
共 50 条
  • [1] Postmastectomy radiotherapy in patients with T1-2N1 breast cancer: a single center experience and a meta-analysis
    Luo, Meng
    Jin, Yao
    Xu, Chunjing
    Chen, Huihui
    Zhang, Kun
    Chen, Qiang
    Jin, Chencan
    Lu, Jinglu
    Wang, Jing
    Huang, Jia
    Deng, Hao
    Jin, Weili
    Zheng, Shu
    Chen, Yiding
    Zhou, Jiaojiao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 9979 - 9990
  • [2] Postmastectomy radiotherapy in patients with T1-2N1 breast cancer: a single center experience and a meta-analysis
    Meng Luo
    Yao Jin
    Chunjing Xu
    Huihui Chen
    Kun Zhang
    Qiang Chen
    Chencan Jin
    Jinglu Lu
    Jing Wang
    Jia Huang
    Hao Deng
    Weili Jin
    Shu Zheng
    Yiding Chen
    Jiaojiao Zhou
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 9979 - 9990
  • [3] Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions
    Wang, Shulian
    Wen, Ge
    Tang, Yu
    Yang, Yong
    Jing, Hao
    Wang, Jianyang
    Zhang, Jianghu
    Zhao, Xuran
    Sun, Guangyi
    Jin, Jing
    Song, Yongwen
    Liu, Yueping
    Fang, Hui
    Zhang, Yujing
    Li, Yexiong
    BMC CANCER, 2020, 20 (01)
  • [4] Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer
    Cao, L.
    Ou, D.
    Shen, K. -W.
    Cai, G.
    Cai, R.
    Xu, F.
    Zhao, S. -G.
    Xu, C.
    Adedjouma, N. Grellier
    Kirova, Y. M.
    Chen, J. -Y.
    CANCER RADIOTHERAPIE, 2018, 22 (01): : 38 - 44
  • [5] The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
    Wei, Jinli
    Jiang, Yizhou
    Shao, Zhimin
    BREAST, 2020, 51 : 40 - 49
  • [6] The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis
    Kim, Kangpyo
    Park, Won
    Kim, Haeyoung
    Cho, Won Kyung
    Kim, Nalee
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Yu, Jonghan
    Chae, Byung Joo
    Lee, Se Kyung
    Ryu, Jai Min
    CANCERS, 2023, 15 (22)
  • [7] Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer
    Luo, Chuanxu
    Zhong, Xiaorong
    Luo, Ting
    Zheng, Hong
    BREAST, 2021, 59 : 308 - 313
  • [8] Nomogram Predicting Locoregional Recurrence to Assist Decision-Making of Postmastectomy Radiation Therapy in Patients With T1-2N1 Breast Cancer
    Luo, Chuanxu
    Zhong, Xiaorong
    Deng, Ling
    Xie, Yuxin
    Hu, Kejia
    Zheng, Hong
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (04): : 905 - 912
  • [9] Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancer
    Liu, Ke
    Li, Guan-Qiao
    Li, Si-Qi
    Chen, Xue-Qin
    Wu, San-Gang
    BREAST, 2025, 79
  • [10] Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy
    Pu, Hongyu
    Luo, Yunbo
    Zhang, Linxing
    Li, Xin
    Li, Fangwei
    Chen, Jingtai
    Qian, Shuangqiang
    Tang, Yunhui
    Zhao, Xiaobo
    Hou, Lingmi
    Gao, Yanchun
    FRONTIERS IN ONCOLOGY, 2023, 13
12345